Immunome Inc (IMNM) insider trading
Every open-market stock purchase and sale by Immunome Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Isaac Barchas (Insider) and 3 others sold $9.4M in the last 90 days.
- Last insider buy: Jean Jacques Bienaime (Insider), $117K, 4 months ago.
Last 12 months: insiders bought $2.3M (8 buys) and sold $23.1M (14 sales). Last close $23.93 on Sep 17, 2026.
Recent IMNM insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 11, 2026 | Jack Higgins (C-suite exec) | Sold | $334K |
| Sep 11, 2026 | Jack Higgins (C-suite exec) | Sold (not open market) | — |
| Sep 11, 2026 | Jack Higgins (C-suite exec) | Bought (not open market) | — |
| Aug 12, 2026 | Isaac Barchas (Insider) | Sold | $301K |
| Aug 11, 2026 | Isaac Barchas (Insider) | Sold | $1.6M |
| Aug 10, 2026 | Isaac Barchas (Insider) | Sold | $264K |
| Aug 7, 2026 | Isaac Barchas (Insider) | Sold | $397K |
| Aug 6, 2026 | Isaac Barchas (Insider) | Sold | $543K |
| Aug 4, 2026 | Kinney Horn (C-suite exec) | Sold | $2.3M |
| Aug 4, 2026 | Kinney Horn (C-suite exec) | Bought (not open market) | — |
| Aug 4, 2026 | Kinney Horn (C-suite exec) | Bought (not open market) | — |
| Jul 23, 2026 | Jack Higgins (C-suite exec) | Bought (not open market) | — |
| Jul 23, 2026 | Jack Higgins (C-suite exec) | Bought (not open market) | — |
| Jul 23, 2026 | Max Rosett (CFO) | Bought (not open market) | — |
| Jul 23, 2026 | Max Rosett (CFO) | Bought (not open market) | — |
| Jul 23, 2026 | Philip Tsai (CTO) | Bought (not open market) | — |
| Jul 23, 2026 | Philip Tsai (CTO) | Bought (not open market) | — |
| Jul 23, 2026 | Robert Lechleider (C-suite exec) | Bought (not open market) | — |
| Jul 23, 2026 | Robert Lechleider (C-suite exec) | Bought (not open market) | — |
| Jul 23, 2026 | Clay B Siegall (CEO) | Bought (not open market) | — |
| Jul 23, 2026 | Clay B Siegall (CEO) | Bought (not open market) | — |
| Jul 23, 2026 | Kinney Horn (C-suite exec) | Bought (not open market) | — |
| Jul 23, 2026 | Sandra G. Stoneman (C-suite exec) | Bought (not open market) | — |
| Jul 23, 2026 | Sandra G. Stoneman (C-suite exec) | Bought (not open market) | — |
| Jul 23, 2026 | Kinney Horn (C-suite exec) | Bought (not open market) | — |
Who's trading IMNM
- Jack Higgins, C-suite exec: sold $538K (2 sales), last Sep 11, 2026
- Isaac Barchas, Insider: sold $13.9M (9 sales), last Aug 12, 2026
- Kinney Horn, C-suite exec: sold $2.3M (2 sales), last Aug 4, 2026
- Sandra G. Stoneman, C-suite exec: other filings, last Jul 23, 2026
- Clay B Siegall, CEO: bought $1.7M (4 buys), last Jul 23, 2026
- Robert Lechleider, C-suite exec: sold $2.3M (5 sales), last Jul 23, 2026
- Philip Tsai, CTO: bought $205K (1 buy), last Jul 23, 2026
- Max Rosett, CFO: sold $2.5M (3 sales), last Jul 23, 2026
- Philip Wagenheim, Insider: sold $1.3M (2 sales), last Jun 10, 2026
- James P Boylan, Insider: other filings, last Jun 10, 2026
- Carol Schafer, Insider: other filings, last Jun 10, 2026
- Sandra M Swain, Insider: other filings, last Jun 10, 2026
- Jean Jacques Bienaime, Insider: bought $351K (6 buys), sold $204K (2 sales), last Jun 10, 2026
Get free alerts when an insider at Immunome Inc files a new trade →